Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil and Metoprolol for RV Function in Preterm Young Adults
NCT03696758Phase 2Completed
- Sponsor
- University of Wisconsin–Madison
- Start
- Oct 2018
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of ASP-001 and metoprolol in Right ventricular dysfunction (RVD) (2 arms), sponsored by University of Wisconsin–Madison. Primary endpoint: Right Ventricular Energetic Efficiency. Started Oct 2018; status: completed.
02
Drugs
ASP-001metoprolol
03
Conditions
Right ventricular dysfunction (RVD)
Beyond the preview
Go deeper on NCT03696758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03696758.